Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Grant or award CMO & Head of Late-Stage Dev. acquired 39,049 shares (grant or award)
  2. 4 Grant or award Director acquired 842 shares (grant or award)
  3. 4 Grant or award Director acquired 269 shares (grant or award)
  4. 4 Grant or award Director acquired 265 shares (grant or award)
  5. 4 Shares withheld for taxes EVP, GM, Dermatology US gave up 537 shares (to pay taxes)
  6. 4 Planned sale President, R&D sold 18,667 shares at $94.24 ($1,759,178)
  7. 4 Planned sale President, R&D sold 18,668 shares at $100.91 ($1,883,788)
  8. 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 185 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP, Head of Incyte Intl gave up 111 shares (to pay taxes)
  10. 4 Grant or award EVP, Head of Incyte Intl acquired 8,911 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 429 shares (to pay taxes)
  18. 4 Planned sale EVP, Head of US Oncology sold 10,856 shares at $109.07 ($1,184,064)
  19. 4 Planned sale EVP & Chief Medical Officer sold 15,634 shares at $101.70 ($1,589,978)
  20. 4 Grant or award Director acquired 241 shares (grant or award)

Page 4 of 82 · 1,626 filings